特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

PoC (ポイントオブケア) 診断薬の世界市場:将来展望

Global Point-of-Care Diagnostics Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 869644
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
PoC (ポイントオブケア) 診断薬の世界市場:将来展望 Global Point-of-Care Diagnostics Market 2019-2025
出版日: 2019年06月10日 ページ情報: 英文
概要

当レポートでは、世界のPoC (ポイントオブケア) 診断の市場の現状と見通しについて分析し、システムの概要や市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、世界全体および地域別の市場動向の見通し (今後7年間分)、セグメント別 (用途別、処方形態別、エンドユーザー別) の詳細動向、最新の市場競争状況、主要企業のプロファイルなどを調査しております。

第1章 分析概要

第2章 市場の概要と考察

  • 市場の範囲
  • アナリストの見解と現在の市場動向
    • 分析のポイント
    • 提言
    • 結論
  • 世界各国の法令・規制

第3章 競争環境

  • 企業一覧
  • 主要戦略の分析
  • 主要企業の分析
    • Abbott Laboratories, Inc.
      • 概要
      • 財務分析
      • SWOT分析
      • 近年の動向
    • F. Hoffmann-La Roche, Ltd.
    • Danaher Corp.
    • EKF Diagnostics Holdings PLC
    • Siemens Healthcare GmbH

第4章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第5章 市場区分

  • 世界のPoC診断薬市場:用途別
    • 心臓疾患
    • 糖尿病
    • 感染症
    • 腫瘍
    • その他 (血液検査、妊娠検査)
  • 世界のPoC診断薬市場:処方形態別
    • 市販薬 (OTC医薬品)
    • 処方薬
  • 世界のPoC診断薬市場:エンドユーザー別
    • 病院・診療所
    • 在宅治療
    • その他 (外来治療)

第6章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、ドイツ、イタリア、スペイン、フランスなど)
  • アジア太平洋地域 (中国、インド、日本など)
  • 他の国々 (RoW)

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson, and Co.
  • Biomeme, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostics Systems, Inc.
  • Danaher Corp.
  • DNAe Group Holdings, Ltd.
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche, Ltd.
  • Instrumentation Laboratory SpA
  • Nova Biomedical Corp.
  • Qiagen N.V.
  • Quidel Corp.
  • Sekisui Diagnostics LLC
  • Siemens Healthcare GmbH
  • Sinocare, Inc.
  • シスメックス
  • Trinity Biotech PLC
図表

List of Tables

  • 1. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 2. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 3. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 4. GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 5. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 7. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 8. GLOBAL OVER-THE-COUNTER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 9. GLOBAL PRESCRIPTION-BASED DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 10. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 11. GLOBAL HOSPITAL AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 12. GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 13. GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 14. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
  • 15. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025($ MILLION)
  • 16. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 17. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 18. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 19. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 20. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 21. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 22. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 23. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 24. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
  • 25. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 26. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE 2018-2025($ MILLION)
  • 27. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
  • 28. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
  • 29. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
  • 30. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)

List of Figures

  • 1. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY APPLICATION, 2018 VS 2025(%)
  • 2. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY PRESCRIPTION MODE, 2018 VS 2025(%)
  • 3. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY END USER, 2018 VS 2025(%)
  • 4. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET SHARE BY GEOGRAPHY, 2018 VS 2025(%)
  • 5. US POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 6. CANADA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 7. UK POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 8. FRANCE POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 9. GERMANY POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 10. ITALY POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 11. SPAIN POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 12. ROE POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 13. INDIA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 14. CHINA POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 15. JAPAN POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 16. REST OF ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
  • 17. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET SIZE, 2018-2025($ MILLION)
目次
Product Code: OMR2019700

Global Point-of-Care Diagnostics Market Size, Share & Trends Analysis Report by Application (Cardiology, Diabetes, Infectious Diseases, Oncology and Other Applications), by Prescription Mode (Over-The-Counter Testing and Prescription-Based Diagnostics), by End-User (Hospital and Clinics, Home Care, and Other), and Forecast, 2019-2025

The point-of-care diagnostics are medical devices used for early diagnosis & monitoring of various diseases such as cancer, diabetes, infectious diseases, and others. There is a high growth opportunity in this market due to the increase in investment by public foundations and new products development. However, the high cost of the device and its installation along with product recall due to technical failure are some of the restraint to the point-of-care diagnostics market.

The global point-of-care diagnostics market is segmented on the basis of application, prescription mode and end user. On the basis of the application, it is further classified into cardiology, diabetes, infectious diseases, oncology and other applications. The infectious disease segment is expected to show a significant growth owing to the increase in the number of affected patients and increasing awareness about infectious disease testing point-of-care devices. On the basis of the prescription mode, the market is classified into the over-the-counter testing and prescription-based diagnostics. Among these, the prescription-based diagnostics segment are expected to show significant growth attributed to lack of awareness on over-the-counter testing devices.

The global point-of-care diagnostics market is further analyzed and segmented on the basis of regions into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have considerable market in terms of market share in the global point-of-care diagnostics market. This is mainly attributed to the high prevalence of diseases, development of healthcare infrastructure and mostly due to the presence of major players such as Abbott Laboratories and Danaher Corp. Asia-Pacific is growing due to increasing quality of the healthcare system and increasing awareness among people in emerging countries, such as India, are the reason for the high market growth.

Key market players operating in the global point-of-care diagnostics market include F. Hoffmann-La Roche Ltd., Danaher Corp., Abbott Laboratories, Inc., bioMerieux SA, and Siemens Healthcare GmbH among others. These companies adopt various strategies such as partnership & collaborations, finding a new market or Product innovations in their core competency in order to stay competitive in the market. For instance, In April 2017, Chembio Diagnostics, Inc., collaborated with FIND to develop Hepatitis-C virus detecting point-of-care device.

Research Methodology

The market study of the global point-of-care diagnostics market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.

The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Point-of-care diagnostics Market Research and Analysis by Application
  • 2. Global Point-of-care diagnostics Market Research and Analysis by Prescription Mode
  • 3. Global Point-of-care diagnostics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global point-of-care diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global point-of-care diagnostics market.
  • Insights about market determinants which are stimulating the global point-of-care diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Study
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott Laboratories, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. F. Hoffmann-La Roche, Ltd.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Danaher Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. EKF Diagnostics Holdings PLC
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Siemens Healthcare GmbH
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Point-of-care Diagnostic Market by Application

5.1.1 Cardiology

5.1.2 Diabetes

5.1.4 Infectious Diseases

5.1.4 Oncology

5.1.5 Other Applications (Haematology Testing, Pregnancy Testing)

  • 5.2. Global Point-of-care Diagnostic Market by Prescription Mode
    • 5.2.1. Over-The-Counter Testing
    • 5.2.2. Prescription-Based Diagnostics
  • 5.3. Global Point-of-care Diagnostic Market by End-User
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Home Care
    • 5.3.3. Other (Ambulatory Care)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. The US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. AccuBioTech Co., Ltd.
  • 7.3. Becton, Dickinson, and Co.
  • 7.4. Biomeme, Inc.
  • 7.5. bioMerieux SA
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. Chembio Diagnostics Systems, Inc.
  • 7.8. Danaher Corp.
  • 7.9. DNAe Group Holdings, Ltd.
  • 7.10. EKF Diagnostics Holdings PLC
  • 7.11. F. Hoffmann-La Roche, Ltd.
  • 7.12. Instrumentation Laboratory SpA
  • 7.13. Nova Biomedical Corp.
  • 7.14. Qiagen N.V.
  • 7.15. Quidel Corp.
  • 7.16. Sekisui Diagnostics LLC
  • 7.17. Siemens Healthcare GmbH
  • 7.18. Sinocare, Inc.
  • 7.19. Sysmex Corp.
  • 7.20. Trinity Biotech PLC